Androgen-deprivation therapy and pancreatic β-cell dysfunction in men

Journal of Diabetes and its Complications

Volumn 30, Issue 3, 2016, Pages 389-390

  Mauvais Jarvis, Franck ^a  

^a TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANDROGEN; GONADORELIN DERIVATIVE; ANDROGEN; TESTOSTERONE;

AGING; ANDROGEN DEFICIENCY; ANDROGEN DEPRIVATION THERAPY; DIABETES MELLITUS; EDITORIAL; GLUCOSE HOMEOSTASIS; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; HYPOGONADISM; INSULIN RESISTANCE; MALE; OBESITY; PANCREAS ISLET BETA CELL; PANCREAS ISLET DISEASE; PATIENT; PRIORITY JOURNAL; PROSTATE CANCER; RISK FACTOR; SUBSTITUTION THERAPY; ADULT; AGED; DEFICIENCY; DIABETES MELLITUS, TYPE 2; DRUG EFFECTS; MIDDLE AGED; PANCREATIC NEOPLASMS; PHYSIOLOGY;

ADULT; AGED; ANDROGEN ANTAGONISTS; ANDROGENS; DIABETES MELLITUS, TYPE 2; HUMANS; HYPOGONADISM; INSULIN-SECRETING CELLS; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; TESTOSTERONE;

EID: 84961905768     PISSN: 10568727     EISSN: 1873460X     Source Type: Journal    
DOI: 10.1016/j.jdiacomp.2016.01.007     Document Type: Editorial

References (19)

1. A.B. Araujo, G.R. Esche, V. Kupelian, A.B. O'Donnell, T.G. Travison, and R.E. Williams J.B. McKinlay Prevalence of symptomatic androgen deficiency in men The Journal of Clinical Endocrinology and Metabolism 92 2007 4241 4247
2. J.E. Faris, and M.R. Smith Metabolic sequelae associated with androgen deprivation therapy for prostate cancer Current Opinion in Endocrinology, Diabetes, and Obesity 17 2010 240 246
3. M. Grossmann, R. Hoermann, G. Wittert, and B.B. Yeap Effects of testosterone treatment on glucose metabolism and symptoms in men with type 2 diabetes and the metabolic syndrome: A systematic review and meta-analysis of randomized controlled clinical trials Clinical Endocrinology 83 2015 344 351
4. G. Hackett, N. Cole, M. Bhartia, D. Kennedy, J. Raju, and P. Wilkinson Testosterone replacement therapy improves metabolic parameters in hypogonadal men with type 2 diabetes but not in men with coexisting depression: The BLAST study The Journal of Sexual Medicine 11 2014 840 856
5. M. Inaba, Y. Otani, K. Nishimura, N. Takaha, A. Okuyama, and M. Koga S. Kasayama Marked hyperglycemia after androgen-deprivation therapy for prostate cancer and usefulness of pioglitazone for its treatment Metabolism 54 2005 55 59
6. T.H. Jones, S. Arver, H.M. Behre, J. Buvat, E. Meuleman, and I. Moncada K.S. Channer Testosterone replacement in hypogonadal men with type 2 diabetes and/or metabolic syndrome (the TIMES2 study) Diabetes Care 34 2011 828 837
7. N.L. Keating, A.J. O'Malley, S.J. Freedland, and M.R. Smith Diabetes and cardiovascular disease during androgen deprivation therapy: Observational study of veterans with prostate cancer Journal of the National Cancer Institute 102 2010 39 46
8. N.L. Keating, A.J. O'Malley, and M.R. Smith Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 24 2006 4448 4456
9. F. Mauvais-Jarvis, R.N. Kulkarni, and C.R. Kahn Knockout models are useful tools to dissect the pathophysiology and genetics of insulin resistance Clinical Endocrinology 57 2002 1 9
10. G. Navarro, C. Allard, W. Xu, and F. Mauvais-Jarvis The role of androgens in metabolism, obesity, and diabetes in males and females Obesity (Silver Spring) 23 2015 713 719
11. J.Y. Oh, E. Barrett-Connor, N.M. Wedick, and D.L. Wingard Endogenous sex hormones and the development of type 2 diabetes in older men and women: The Rancho Bernardo study Diabetes Care 25 2002 55 60
12. M.A. Perlmutter, and H. Lepor Androgen deprivation therapy in the treatment of advanced prostate cancer Reviews in Urology 9 Suppl. 1 2007 S3 S8
13. K.S. Polonsky Lilly Lecture 1994. The beta-cell in diabetes: from molecular genetics to clinical research Diabetes 44 1995 705 717
14. M. Prentki, and C.J. Nolan Islet beta cell failure in type 2 diabetes The Journal of Clinical Investigation 116 2006 1802 1812
15. Standards of medical care in diabetes - 2015: Summary of revisions Diabetes Care 38 Suppl.:S4 2015 10.2337/dc15-S003
16. R.K. Stellato, H.A. Feldman, O. Hamdy, E.S. Horton, and J.B. McKinlay Testosterone, sex hormone-binding globulin, and the development of type 2 diabetes in middle-aged men: Prospective results from the Massachusetts male aging study Diabetes Care 23 2000 490 494
17. U.K. Prospective diabetes study 16. Overview of 6 years' therapy of type II diabetes: A progressive disease. U.K. Prospective Diabetes Study Group Diabetes 44 1995 1249 1258
18. C. Weyer, C. Bogardus, D.M. Mott, and R.E. Pratley The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus The Journal of Clinical Investigation 104 1999 787 794
19. M. Zitzmann Testosterone deficiency, insulin resistance and the metabolic syndrome Nature Reviews. Endocrinology 5 2009 673 681